Integrating long-acting injectable treatment to improve medication adherence among persons living with HIV and opioid use disorder: study protocol
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Integrating long-acting injectable treatment to improve medication adherence among persons living with HIV and opioid use disorder: study protocol ; volume:18 ; number:1 ; day:14 ; month:10 ; year:2023 ; pages:1-11 ; date:12.2023
Addiction science & clinical practice ; 18, Heft 1 (14.10.2023), 1-11, 12.2023
- Creator
-
Langdon, Kirsten J.
Hitch, Anthony E.
Collins, Alexandra B.
Beckwith, Curt G.
Becker, Sara
Tashima, Karen
Rich, Josiah D.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13722-023-00418-6
- URN
-
urn:nbn:de:101:1-2024020613182540737573
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Langdon, Kirsten J.
- Hitch, Anthony E.
- Collins, Alexandra B.
- Beckwith, Curt G.
- Becker, Sara
- Tashima, Karen
- Rich, Josiah D.
- SpringerLink (Online service)
Other Objects (12)
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Patients’ goals when initiating long-acting injectable buprenorphine treatment for opioid use disorder: findings from a longitudinal qualitative study
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Long-Acting Reversible Contraception
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Patients’ goals when initiating long-acting injectable buprenorphine treatment for opioid use disorder: findings from a longitudinal qualitative study
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Long-Acting Reversible Contraception
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Patients’ goals when initiating long-acting injectable buprenorphine treatment for opioid use disorder: findings from a longitudinal qualitative study
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Long-Acting Reversible Contraception